Benzinga | May 10, 2021 06:52AM EDT

Eagle Pharmaceuticals Q1 EPS $0.24 Misses $0.65 Estimate, Sales $41.20M Miss $45.41M Estimate

Eagle Pharmaceuticals (NASDAQ:EGRX) reported quarterly earnings of $0.24 per share which missed the analyst consensus estimate of $0.65 by 63.08 percent. This is a 71.43 percent decrease over earnings of $0.84 per share from the same period last year. The company reported quarterly sales of $41.20 million which missed the analyst consensus estimate of $45.41 million by 9.27 percent. This is a 10.47 percent decrease over sales of $46.02 million the same period last year.